The quickest way to damage a company is to start believing it has a soul.
You are on the board of a clinical-stage biotech. The CEO, who also sits on the board, is presenting. He is a physician who still sees patients. Before he became a CEO, he spent years in academic medicine running sponsored trials. Sponsors paid for those trials. The work was real and the patients were real. The money was always someone else's.
Now the money belongs to investors, and you are responsible for overseeing it.
The deck is dense with molecular diagrams and patient anecdotes. The science is elegant. He presents it with the quiet authority of a man who has spent his career at the bedside, and you can feel his compassion in the room. He is the doctor you would want treating your own family.
Then someone asks about the burn rate.
His posture stiffens, slightly. He does not answer the question. He talks about the patients. "These patients have no alternatives," he says. "I have been treating them my whole career. If we stop this trial, we are abandoning them."
The room goes quiet. Nobody wants to be the person who questions a doctor about dying patients.
Compassion, however real, is not a financial plan.
A career of clinical authority fills the room like a gas. It does not poison anyone. It just makes it hard to breathe and ask a direct question at the same time.
You notice something else. In academic medicine, he never needed the habit of critically evaluating his own clinical data. The sponsors paid and the university supplied the credibility. His job was to recruit patients and present results. That skill set does not transfer to a boardroom where the investors' money is running out and the data is not doing what the slide deck says.
An outside director presses on the endpoints. The CEO's tone sharpens, politely, with a precision designed to remind everyone that he is the physician in the room and they are not. He has done this before, and it works. The director retreats. The question dies. The trial gets extended and the treasury drains a little more.
His compassion is real. He is also wrong, and the board just decided on deference instead of evidence. That is the Higher Calling Trap at its most effective: sincerity so convincing that questioning it feels like cruelty.
I have heard the same sentence at three companies, from physicians and from people who never trained as one: patients are on the line. The patients were real every time. So was the money.
It is older than this boardroom
Every collapse begins with conviction. Theranos wrapped itself in the language of access and public health. FTX said it was funding global good. In both, moral language muffled the simplest questions: where is the cash, who decides, what happens if we are wrong.
Uber changed only after lawsuits and an investor revolt forced a leadership overhaul. The correction came from outside the belief system. Governance restored what rhetoric had replaced.
Fraud is the easy case. Elizabeth Holmes knew she was lying, and eventually someone found out. The harder case is the founder who believes, whose compassion is real and whose conviction is earned. A calling produces a dissonance that grows stronger the further reality drifts from belief. Leaders who feel called begin to feel exempt from ordinary accountability. Numbers lose meaning. Questions feel like betrayal.
When the story of virtue becomes more important than the proof of results, conviction turns from energy into anesthesia.
The Bill Campbell Antidote
Bill Campbell spent decades coaching leaders across technology and media. His gift was pairing care with confrontation. In his coaching, care and candor came as a pair.
The question I take from him is simple: what are you trying to do, and how will you know when you have done it? Purpose mattered to him, but proof mattered more. He taught leaders to make decisions in the room rather than in whispers afterward, to treat feedback as signal rather than threat, and to keep the mission in service of the result.
I met him once, at the Old Pro in Palo Alto, where UCLA alumni gathered to watch the Bruins play Stanford or Cal. He was holding court. Someone pointed him out, I said hello, and he gave me one of his big hugs and wished me luck with the Bruins. That was all. Years later, after reading how he coached, I understood the hug was part of the method: make people welcome first, so they can take the hard question second.
A practical test before the next big decision
If you lead a team or sit on a board, run this before the next big decision.
Write the mission in one sentence. Then set it aside.
List the three outcomes that would prove success. Use numbers, dates and independent verification.
Name the person who can stop the project if those outcomes do not appear on time. Give that person real authority.
Ask for the strongest case against your position. Put the person who makes it in the room, and let them speak first.
Decide how much you are willing to lose if you are wrong. Cap the exposure before the debate begins.
If you still believe after all of that, proceed. If not, pause.
You can care about the mission tomorrow.
Most of us learned the rule early: show your work, check your math, admit when you are wrong. Good governance is that rule written in corporate form.
When the next leader tells you their company is a calling, ask for a balance sheet.